Stereotaxis (STXS) Total Non-Current Liabilities (2010 - 2026)

Stereotaxis' (STXS) quarterly Total Non-Current Liabilities came in at $29.3 million in Q1 2026, down 6.23% year-on-year from $31.3 million in Q1 2025, and up 1.8% on a QoQ basis from $28.8 million in Q4 2025.

Stereotaxis (STXS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Total Non-Current Liabilities data on file, last reported at $29.3 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 6.23% year-over-year to $29.3 million in Q1 2026; TTM through Mar 2026 was $29.3 million, a 6.23% decrease from a year earlier, with the FY2025 full-year figure at $28.8 million, down 1.23% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $29.3 million, up from $28.8 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for STXS reached as high as $34.7 million in Q3 2024 and fell as low as $19.2 million in Q2 2024.
  • Historically, Total Non-Current Liabilities has averaged $25.0 million across 5 years, with a median of $21.4 million in 2022.
  • Across the five-year window, Total Non-Current Liabilities declined 10.5% in 2023 and surged 73.53% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $21.4 million in 2022, then slipped by 6.94% to $19.9 million in 2023, then surged by 46.22% to $29.2 million in 2024, then decreased by 1.23% to $28.8 million in 2025, then gained by 1.8% to $29.3 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $29.3 million in Q1 2026, $28.8 million in Q4 2025, and $33.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 6.48 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 1.92 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 48.37 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 17.13 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 941.16 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 996.30 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 4.24 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 8.65 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 2.06 Bn
10 Stereotaxis 136.49 Mn 121.87 Mn 3.79 Mn 29.32 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.32 Mn
Dec 31, 2025 28.81 Mn
Sep 30, 2025 32.95 Mn
Jun 30, 2025 33.31 Mn
Mar 31, 2025 31.27 Mn
Dec 31, 2024 29.17 Mn
Sep 30, 2024 34.66 Mn
Jun 30, 2024 19.20 Mn
Mar 31, 2024 19.38 Mn
Dec 31, 2023 19.95 Mn
Sep 30, 2023 20.19 Mn
Jun 30, 2023 21.30 Mn
Mar 31, 2023 21.37 Mn
Dec 31, 2022 21.43 Mn
Sep 30, 2022 22.56 Mn
Jun 30, 2022 20.95 Mn
Mar 31, 2022 19.32 Mn
Dec 31, 2021 21.34 Mn
Sep 30, 2021 21.55 Mn
Jun 30, 2021 15.08 Mn